The audio of the presentation is available on the Oclaro website. Jerry Turin - Oclaro CFO - answered questions for 33 minutes. His answers were very similar to the Oclaro recent quarterly report that Oclaro has an active program to reduce costs, but breakeven will require an increase in sales. He gave positive remarks about sales progress but no sales forecast real info. There was a mention that some of the $23 million in insurance money could be received soon. I am encouraged that Oclaro appears to be serious about cutting costs and increasing margins. However, there needs to be a cyclical upturn in optical sales for Oclaro to show substantial progress. Analysts are predicting that this cyclical upturn will start in the second half of 2013 and into 2014. This cyclical upturn is the key issue in the recovery of the OCLR stock.